Purchase Order 75N93023P00476
Award Date
7/1/23
Potential Completion Date
6/30/24
Potential Value
$39K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $48,209 firm fixed price purchase order to Illumina, Inc. to provide two Nextseq 2000 Silver Support Plans. The solicitation sought comparable services to support NIAID's genomic research efforts, including full parts, labor, and travel coverage; reagent replacement for hardware failures; remote and on-site technical support; software and...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,275 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for one NEXTSEQ 2000 SEQUENCING SYSTEM to support ongoing COVID-19 and infectious disease research. Delivery is required by January 31, 2023 in Bethesda, Maryland per the original solicitation seeking offers for the Illumina NextSeq-2000 sequencing system and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer, for a NextSeq 550 Sequencing System and associated support services. The potential value of the contract is $316,250.00. There was no set-aside used for this award. The contract was issued under the statutory authority of 41 U.S.C. 253 (c) (1), citing only one source available for...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. to provide an Illumina NextSeq 550 sequencing system. The potential value of the contract is $273,655.08. There was no set-aside designation for this award. Illumina, a for-profit manufacturer of genetic and genomic analysis instruments and reagents, has provided a range of sequencing systems and related...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $53,029.50 firm-fixed price purchase order to Illumina, Inc. for a one-year service plan covering preventative maintenance, full parts and labor coverage, reagent replacement, remote technical support, and software/hardware updates for the agency's Illumina NextSeq 2000 sequencing equipment at their Laboratory of Viral Diseases. This purchase was made under full and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,236.05 firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of Illumina Sequencing Kits and will be performed in San Diego, California. The award does not have a set-aside designation. Illumina has previously provided...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $27,385.82 firm fixed price delivery order to Illumina, Inc. of San Diego, California. The delivery order is for Illumina sequencing reagents to support genomic research efforts. No set-aside provisions were applied to this award placed under an existing sequencing technology contract vehicle. The contract expires on March 21, 2024 and will provide the...